Subscribe


Pharmacy Daily articles (18255 found)


Fri 15 Sep 17

Dementia-cardiac link


Pharmacy Daily

A WORLD-FIRST experiment by a University of South Australia cognitive neuroscientist could mitigate the impact of heart surgery on thousands of older Australians at risk of dementia.


Fri 15 Sep 17

PBS pricing Oct cycle


Pharmacy Daily

THE pricing adjustments for the Oct Cycle of Pharmaceutical Benefits Scheme (PBS) reductions to take effect 01 Oct have now been posted on the PBS website.


Fri 15 Sep 17

Managing codeine stocks post 01 Feb


Pharmacy Daily

THE Therapeutic Goods Administration (TGA) has posted an update on how to manage stocks of products containing codeine following their rescheduling to S4 on 01 Feb 2018.


Fri 15 Sep 17

Global AF awareness


Pharmacy Daily

ATRIAL fibrillation (AF) awareness is being championed by the AF Association (AFA) calling for early identification of the undiagnosed person with AF.


Fri 15 Sep 17

AMR still dominates at EMA


Pharmacy Daily

THE European Medicines Agency (EMA) is hosting a joint meeting with the European Centre for Disease Prevention and Control (ECDC) to discuss antimicrobial resistance (AMR).


Fri 15 Sep 17

Pharmacy vaccination guide


THE Pharmacy Guild of Australia has developed a Vaccination Service Business Support Guide and Workbook to provide pharmacy owners with information on how to implement a vaccination service within their pharmacy to ensure they are providing a quality and consistent service.


Fri 15 Sep 17

Pharmintercom tracks trends


NATIONAL president of the Pharmacy Guild of Australia George Tambassis hosted the presidents and ceos of the national bodies for community pharmacy from the United Kingdom, Ireland, New Zealand, the United States, Canada and South Africa at Pharmintercom last week.


Thu 14 Sep 17

Travel Specials 14 Sep 17


Pharmacy Daily

WELCOME to Pharmacy Daily's travel feature.


Thu 14 Sep 17

Dispensary Corner 14 Sep 17


IS TASTE the key to a successful long lasting marriage.


Thu 14 Sep 17

Jardiance supports


Pharmacy Daily

THE latest data on the use of Boehringer Ingelheim's Jardiance (empagliflozin) presented at this year's meeting of the European Association for the Study of Diabetes (EASD) demonstrated lower risk of cardiovascular death compared with placebo regardless of background metformin or sulphonylurea use.




Register for Pharmacy Daily subscriptionPharmacy Daily is Australia's favourite pharmacy industry publication, distributed by email to people across the industry every weekday since 2007. To sign up for a FREE subscription to Pharmacy Daily click on the button at right.